Steve E. Krognes Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Steve E. Krognes is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 31,794 shares of DNLI, which is worth approximately $467,053. The most recent transaction as insider was on Feb 07, 2021, when has been sold 4,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.8K
23.44% 3M change
7.59% 12M change
Total Value Held $467,053

Steve E. Krognes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2021
BUY
Exercise of conversion of derivative security
-
4,250 Added 22.76%
14,427 Common Stock

Also insider at

GRTS
Gritstone bio, Inc. Healthcare
Director
GH
Guardant Health, Inc. Healthcare
Director
PLRX
PLIANT THERAPEUTICS, INC. Healthcare
Director
SEK

Steve E. Krognes

Director
South San Francisco, CA

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI